Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AMGEN INC
Report date May 09, 2006 · Filed May 11, 2006
Section 16 reporting ended · disclosed 2006-05-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 1,604,988 |
Reported balance
After 2006-05-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2006-05-09 · Gift · Disposed 28,300 · Balance 1,604,988 |
| Common StockSEC Table I · non-derivative | IndirectBy Partnership | 350,000 |
Reported balance
Holding disclosure · report date 2006-05-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 350,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2004 Filed Jan 28, 2004 18:02 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 11,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-004871 · rrd30540.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 861,056 F1 · balance_after: (FPJ 01.27.04) Does not include (i) 720,800 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner and (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A intrests of Amgen Clinical Partners, L.P. Further, the reporting person disclaims beneficial of the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 18:02 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 38,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-004871 · rrd30540.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,009,847 F1 · balance_after: (FPJ 01.27.04) Does not include (i) 720,800 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner and (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A intrests of Amgen Clinical Partners, L.P. Further, the reporting person disclaims beneficial of the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| January 20, 2004 Filed Jan 21, 2004 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 22,400 | $6.19 Strike: $6.19 | $138,600.00 |
DisclosureSEC source: 0001181431-04-003629 · rrd29625.xml · derivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,400 shares Expires 2004-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2004 Filed Jan 21, 2004 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 22,400 | $6.19 | $138,600.00 |
DisclosureSEC source: 0001181431-04-003629 · rrd29625.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FPJ 01.20.04) Does not include (i) 720,800 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner, (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 872,416 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $60.20 | $601,990.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 15 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 872,416 Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $60.18 | $601,820.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 14 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 882,416 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 16,400 | $60.17 | $986,837.20 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 13 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 892,416 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $60.15 | $601,500.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 12 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 908,816 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $60.06 | $1,201,200.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 918,816 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $60.18 | $300,910.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 720,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $60.18 | $300,900.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 725,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $60.12 | $300,600.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 730,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 30,000 | $60.10 | $1,803,000.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 735,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $60.08 | $600,780.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 765,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.99 | $299,950.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 785,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 6,400 | $59.90 | $383,360.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 790,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.77 | $298,850.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 797,200 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 19, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.69 | $298,450.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 802,200 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 18, 2003 Filed Nov 20, 2003 00:02 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $60.05 | $600,500.00 |
DisclosureSEC source: 0001181431-03-031882 · rrd23377.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 775,800 F1 · balance_after: (FPJ 11/19/03) Does not include: (i) 1,025,629 shares directly owned by reporting person or (ii) 4 units of contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner. Reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities or of the Partnership's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $59.48 | $594,750.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 14 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,025,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.45 | $297,250.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 13 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.43 | $297,130.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 12 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.41 | $297,050.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,045,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.40 | $297,000.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.36 | $296,800.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 15,000 | $59.30 | $889,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $59.29 | $592,900.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,075,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $59.25 | $592,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 6,000 | $59.20 | $355,200.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.19 | $295,950.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $59.10 | $295,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $58.90 | $294,500.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $58.80 | $294,000.00 |
DisclosureSEC source: 0001181431-03-031723 · rrd23275.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,629 F1 · balance_after: (FPJ 11/17/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the benficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is a general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| August 14, 2003 Filed Aug 15, 2003 20:15 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-018975 · rrd16180.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,629 F1 · balance_after: (1) FPJ 8/14/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report should not be deemed an admission that the reporting person is the beneficial owner the securities for the purpose of Section 16 of the Securities Exchange Act of 1934; (ii) 807,200 shares held by Asset Management Partners ("AMP") for which the reporting person is the general partner; and (iii) 4 units of contractual contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,000 | $64.05 | $192,150.00 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 807,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. F2 · ownership.nature: Note: 2(FPJ-5/3/03) Does not include: (i) 1,122,429 shares held as direct ownership by report person; (ii) 4 units of contractual contingent payment rights held by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P.; and (iii) 938,816 shares held as indirect ownership by the spouse of reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,000 | $63.92 | $191,760.00 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 810,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,000 | $63.84 | $191,520.00 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 813,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,744 | $63.80 | $175,067.20 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 816,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 29, 2003 Filed May 30, 2003 17:15 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-009404 · rrd10130.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122,429 F1 · balance_after: Note: 1 (FPJ 5/29/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 818,944 shares held by Asset Management Partners ("AMP") for which the reporting persons is a general partner; and (iii) 4 units of contractural contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 13 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 938,816 F1 · kind: Note: 1 (FPJ-05/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. F3 · balance_after: Note: 3 (FPJ cj 05/15/03) Includes 80,000 shares previously held by AMP and held as indirect ownership by the spouse of the reporting person. Shares were distributed by AMP on May 15, 2003 to the spouse of the reporting person in a transaction under rule 16(a)13. The reporting person disclaims beneficial ownership of the securities indicated and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $62.64 | $62,640.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 12 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 818,944 F2 · balance_after: Note: 2 (FPJ-05/15/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. In addition, AMP holds indirectly 4 units of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,800 | $62.62 | $112,716.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 819,944 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,600 | $62.61 | $162,786.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 821,744 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,400 | $62.60 | $150,240.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 824,344 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 894 | $62.59 | $55,956.35 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 826,744 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,100 | $62.59 | $194,029.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 827,638 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,300 | $62.58 | $81,354.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 830,738 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 500 | $62.57 | $31,285.50 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 832,038 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 8,706 | $62.57 | $544,734.42 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 832,538 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,700 | $62.56 | $168,912.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 841,244 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.